ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1,4,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
1,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,6,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
3,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
3,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,4,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
4,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
4,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
4,3,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
4,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
5,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
5,2,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
6,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
6,2,Squamous cell carcinoma of lung,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
7,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
7,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
9,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,2,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
10,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
11,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
11,2,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
12,1,Autoimmune myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
12,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
13,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
14,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
14,2,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
15,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
16,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
17,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
17,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
18,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,Y
19,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
19,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
20,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
20,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
21,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
21,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
21,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
22,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
23,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
23,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
23,3,Lichen nitidus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
23,4,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
23,5,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
23,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Disease risk factor,Social issues NEC,Lifestyle issues,SocCi,N
25,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
25,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
25,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
26,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
27,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
28,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
28,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
30,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
31,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
31,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
32,1,Metastases to chest wall,Metastases to specified sites,Metastases,Neopl,N
32,2,Metastases to lymph nodes,Metastases to specified sites,Metastases,Neopl,N
32,3,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
33,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
33,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
33,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
35,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
36,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,Y
37,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
37,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
38,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
39,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
39,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
39,3,Myelofibrosis,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
40,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
40,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
40,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,4,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
40,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,7,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
40,8,Myelopathy,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,Y
40,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
40,10,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
40,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
41,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
41,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
42,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
44,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
45,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
46,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,2,SJS-TEN overlap,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
46,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
47,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
47,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
48,1,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
49,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
49,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
49,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
50,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
51,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
52,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
53,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
53,3,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
53,4,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
54,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
54,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
55,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
56,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
57,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
58,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
59,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
59,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
59,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
59,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
60,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
61,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
62,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
63,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
64,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,1,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
65,2,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
66,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
67,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
68,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
69,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
69,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
69,3,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
69,4,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
70,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
71,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
71,3,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
72,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
72,2,Neck dissection,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
72,3,Parotidectomy,Salivary gland therapeutic procedures,Head and neck therapeutic procedures,Surg,N
72,4,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
72,5,Skin squamous cell carcinoma recurrent,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
72,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
73,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
74,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
75,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
76,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
77,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
78,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
79,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
80,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
81,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
82,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
82,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
83,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
83,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
83,3,Head and neck cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
83,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
84,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
85,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
86,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
88,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
89,1,Adrenocorticotropic hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
90,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
91,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
92,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
93,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
94,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
94,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
94,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
94,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
94,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
94,6,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
94,7,Lagophthalmos,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
94,8,Lung squamous cell carcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
94,9,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
94,10,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
94,12,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
95,1,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
96,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
97,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
98,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
99,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
100,1,Acute febrile neutrophilic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
100,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
100,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
101,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
101,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
101,4,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
102,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
104,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
106,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
107,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
108,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
109,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
111,2,Resorption bone increased,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
111,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
111,4,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
112,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
113,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
114,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
115,1,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
116,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
117,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
118,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
119,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
120,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
121,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
121,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
122,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
122,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
123,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
125,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
125,4,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
126,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
127,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
128,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
